Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lisinopril in Extracapillary Glomerulonephritis
NCT02682459Phase 2Unknown
- Start
- Feb 2016
- Primary completion
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of lisinopril in Extracapillary glomerulonephritis (CGN) (2 arms). Primary endpoint: Extent of extracapillary proliferation on light microscopy at 18 months. Status: unknown.
02
Drugs
lisinopril
03
Conditions
Extracapillary glomerulonephritis (CGN)
Beyond the preview
Go deeper on NCT02682459.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02682459.